FDA
approval
· 2014-04-07
FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
Summary
FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP, resulting in updated labeling for the HIV-1 protease inhibitor. The a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PREZISTA (DARUNAVIR)